Suppr超能文献

非小细胞肺癌患者术后肺部感染的危险因素:基于回归模型的分析及列线图预测模型的构建

Risk factors for postoperative pulmonary infection in patients with non-small cell lung cancer: analysis based on regression models and construction of a nomogram prediction model.

作者信息

Ding Zhouzhou, Wang Xiuqi, Jiang Song, Liu Jichun

机构信息

Department of Cardiothoracic Surgery, The First Affilliated Hospital of Nanchang University No. 17, Yongwai Zheng Street, Nanchang 330006, Jiangxi, China.

Department of Gastroenterology, The First Affilliated Hospital of Nanchang University No. 17, Yongwai Zheng Street, Nanchang 330006, Jiangxi, China.

出版信息

Am J Transl Res. 2023 May 15;15(5):3375-3384. eCollection 2023.

Abstract

OBJECTIVE

This study was designed to analyze risk factors for postoperative pulmonary infection (PPI) in patients with non-small cell lung cancer (NSCLC) based on regression models and to construct a corresponding nomogram prediction model.

METHODS

A total of 244 patients with NSCLC who received surgical treatment from June 2015 to January 2017 were retrospectively analyzed. According to the PPI, they were assigned to a pulmonary infection group (n=27) or non-pulmonary infection group (n=217). The independent risk factors for PPI in NSCLC patients were screened through least absolute shrinkage and selection operator (LASSO) and logistic regression analysis, and a corresponding nomogram prediction model was constructed.

RESULTS

A total of 244 NSCLC patients were included, including 27 with PPI (11.06%). According to LASSO regression-based screening, age, diabetes mellitus (DM), tumor node metastasis (TNM) staging, chemotherapy regimen, chemotherapy cycle, post-chemotherapy albumin (g/L), pre-chemotherapy KPS and operation time were all significant and found to be the influencing factors for PPI. The risk model constructed based on LASSO was 0.0035770333 + (0.0020227686* age) + (0.057554487* DM) + (0.016365428* TNM staging) + (0.048514458* chemotherapy regimen) + (0.00871801* chemotherapy cycle) + (-0.002096683* post-chemotherapy albumin (g/L) + (-0.00090206* pre-chemotherapy Karnofsky performance score (KPS)) + (0.000296876* operation time). The pulmonary infection group got significantly higher risk scores than the non-pulmonary infection group (P<0.0001). According to receiver operating characteristic (ROC) curve-based analysis, the area under the curve (AUC) of risk score in predicting pulmonary infection was 0.894. Based on 4 independent predictors, a risk-prediction nomogram model was constructed to predict pulmonary infection in NSCLC patients after surgery. The internal verification C-index was 0.900 (95% CI: 0.839-0.961), and the calibration curves were well fitted with the ideal ones.

CONCLUSION

The prediction model based on a regression model for PPI in NSCLC patients demonstrates good prediction efficiency, which is conducive to early screening of high-risk patients and further improvement of treatment regimen.

摘要

目的

本研究旨在基于回归模型分析非小细胞肺癌(NSCLC)患者术后肺部感染(PPI)的危险因素,并构建相应的列线图预测模型。

方法

回顾性分析2015年6月至2017年1月期间接受手术治疗的244例NSCLC患者。根据是否发生PPI,将他们分为肺部感染组(n = 27)和非肺部感染组(n = 217)。通过最小绝对收缩和选择算子(LASSO)及逻辑回归分析筛选NSCLC患者发生PPI的独立危险因素,并构建相应的列线图预测模型。

结果

共纳入244例NSCLC患者,其中27例发生PPI(11.06%)。根据基于LASSO回归的筛选,年龄、糖尿病(DM)、肿瘤淋巴结转移(TNM)分期、化疗方案、化疗周期、化疗后白蛋白(g/L)、化疗前KPS评分及手术时间均具有显著性,且均为PPI的影响因素。基于LASSO构建的风险模型为0.0035770333 +(0.0020227686×年龄)+(0.057554487×DM)+(0.016365428×TNM分期)+(0.048514458×化疗方案)+(0.00871801×化疗周期)+(-0.002096683×化疗后白蛋白(g/L)+(-0.00090206×化疗前卡氏功能状态评分(KPS))+(0.000296876×手术时间)。肺部感染组的风险评分显著高于非肺部感染组(P<0.0001)。根据基于受试者工作特征(ROC)曲线的分析,风险评分预测肺部感染的曲线下面积(AUC)为0.894。基于4个独立预测因素,构建了风险预测列线图模型以预测NSCLC患者术后的肺部感染。内部验证C指数为0.900(95%CI:0.839 - 0.961),校准曲线与理想曲线拟合良好。

结论

基于回归模型的NSCLC患者PPI预测模型显示出良好的预测效率,有利于早期筛查高危患者并进一步优化治疗方案。

相似文献

5
[Risk factor analysis on body mass rebound after laparoscopic sleeve gastrectomy and establishment of a nomogram prediction model].
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Oct 25;25(10):913-920. doi: 10.3760/cma.j.cn441530-20220418-00159.
6
Establishment and validation of a nomogram for progression to diabetic foot ulcers in elderly diabetic patients.
Front Endocrinol (Lausanne). 2023 Apr 4;14:1107830. doi: 10.3389/fendo.2023.1107830. eCollection 2023.
8
[Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Nov 25;23(11):1059-1066. doi: 10.3760/cma.j.cn.441530-20200103-00004.
9
Nomogram for prediction of peritoneal metastasis risk in colorectal cancer.
Front Oncol. 2022 Nov 7;12:928894. doi: 10.3389/fonc.2022.928894. eCollection 2022.

引用本文的文献

5
Risk factors for postoperative pulmonary infections in non-small cell lung cancer: a regression-based nomogram prediction model.
Am J Cancer Res. 2024 Nov 15;14(11):5365-5377. doi: 10.62347/BIBD8425. eCollection 2024.
7
Risk factors for pulmonary infection in patients with non-small cell lung cancer: a Meta-analysis.
BMC Pulm Med. 2024 Jul 22;24(1):353. doi: 10.1186/s12890-024-03171-x.
8
The impact of concurrent bacterial lung infection on immunotherapy in patients with non-small cell lung cancer: a retrospective cohort study.
Front Cell Infect Microbiol. 2023 Aug 29;13:1257638. doi: 10.3389/fcimb.2023.1257638. eCollection 2023.

本文引用的文献

1
Development and Validation of a Nomogram for Predicting Postoperative Pulmonary Infection in Patients Undergoing Lung Surgery.
J Cardiothorac Vasc Anesth. 2022 Dec;36(12):4393-4402. doi: 10.1053/j.jvca.2022.08.013. Epub 2022 Aug 19.
3
Applying logistic LASSO regression for the diagnosis of atypical Crohn's disease.
Sci Rep. 2022 Jul 5;12(1):11340. doi: 10.1038/s41598-022-15609-5.
4
Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology.
Curr Oncol. 2022 Mar 9;29(3):1828-1839. doi: 10.3390/curroncol29030150.
5
Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China.
Front Public Health. 2021 Dec 10;9:743558. doi: 10.3389/fpubh.2021.743558. eCollection 2021.
8
Targeted therapy of non-small cell lung cancer.
Klin Onkol. 2021 Spring;34(Supplementum 1):48-52. doi: 10.48095/ccko2021S48.
10
Strategic targeting of non-small-cell lung cancer utilizing genetic material-based delivery platforms of nanotechnology.
J Biochem Mol Toxicol. 2021 Jul;35(7):e22784. doi: 10.1002/jbt.22784. Epub 2021 Apr 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验